These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

14 related articles for article (PubMed ID: 2284427)

  • 1. [Case of plasmacytic leukemia with complete remission and 1-year survival after a combined 5-drug sequence therapy].
    Anisimowicz J; Mizan K
    Pol Tyg Lek; 1984 Sep; 39(36):1209-10. PubMed ID: 6504747
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of the successful treatment of acute plasmablastic leukemia].
    Rekhtina IG; Shchekochikhin SM
    Ter Arkh; 1997; 69(11):70-1. PubMed ID: 9483754
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of acute non lymphocytic leukemia. Results of a prospective trial of daunorubicin, arabinosylcytosine and 6-thioguanine (DAT) versus DAT plus vindesine and etoposide.
    Bandini G; Baccarani M; Cavazzini G; Battista R; Leoni F; Morra E; Comotti B; Scapoli G; Todeschini G; Mangoni L
    Haematologica; 1987; 72(5):431-7. PubMed ID: 3121465
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
    Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
    Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
    [No Abstract]   [Full Text] [Related]  

  • 5. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary plasmacytic leukemia--evaluation of the effectiveness of treatment].
    Gola A; Nowicka J; Niewolna M; Radomyska W
    Przegl Lek; 1990; 47(7):568-70. PubMed ID: 2284427
    [No Abstract]   [Full Text] [Related]  

  • 7.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.